Janney Analyst Starts Clovis Oncology At Buy, Expects Regulatory Approvals Coming In 2016
December 17, 2015 at 09:51 AM EST
The share price of Clovis Oncology Inc (NASDAQ: CLVS) has appreciated 7.57 percent in the last month, after having fallen 70.08 ...